Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Bioptigen logo — Explore groundbreaking ophthalmic imaging without boundaries...

Bioptigen

Explore groundbreaking ophthalmic imaging without boundaries, from zebrafish to elephants, with our real-time, high-resolution, near-infrared technology.

Founded 2004 Series Unknown Total: $1.50M Biotechnology, Health Care +1

General Information

Company Name Bioptigen
Founded Year 2004
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series Unknown
Social

Get notified when Bioptigen moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Bioptigen

Bioptigen is an ISO 13485-certified medical device company specializing in creating advanced ophthalmic imaging solutions. The company's Envisu™ R-class systems offer non-invasive imaging capabilities for a wide range of animals, from zebrafish to elephants, using low-power, near-infrared light to produce real-time, high-resolution, volumetric images of eye structures. With CE approval obtained, Bioptigen is positioned to market its hand-held Envisu R2000 systems for preclinical use and C2000 systems for clinical applications within the EU. Since its foundation in 2004, Bioptigen has garnered significant attention within the Biotechnology, Health Care, and Medical Devices industries. The latest notable development for Bioptigen was a $1.50M Venture Round investment on 07 March 2011.

Taxonomy: Ophthalmic Imaging, Near-Infrared Technology, ISO 13485 Certification, Envisu R-Class Systems, Biomedical Imaging, Animal Ocular Imaging, Preclinical Imaging, Clinical Imaging, Zebrafish, Elephants, Volumetric Imaging, CE Approval, Non-Invasive Imaging, Bioptigen Inc.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 07 Mar 2011

Bioptigen Alternatives & Competitors

Bioptigen vs
Aqueti
Aqueti United States

100-Megapixel Array Cameras for Security, Surveillance and Analytics

Series A
11 employees
Media
Bioptigen vs
MinXray, Inc.
MinXray, Inc. United States

The gold standard in portable digital radiography and x-ray equipment.

18 employees
Health Care, Manufacturing
Bioptigen vs
ONI Medical Systems, Inc.
ONI Medical Systems, Inc.

Advancing imaging excellence for precise musculoskeletal care across hospitals and orthopedic practi...

Post Ipo Equity
Health Care

FAQ About Bioptigen

Explore groundbreaking ophthalmic imaging without boundaries, from zebrafish to elephants, with our real-time, high-resolution, near-infrared technology.
Bioptigen was founded in 2004.
Bioptigen operates in the following industries: Biotechnology, Health Care, Medical Devices.
Bioptigen has completed 1 funding round, raising a total of $1.50M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Bioptigen include Aqueti, MinXray, Inc., ONI Medical Systems, Inc., ScImage, Inc., Medical Equipment of Florida. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bioptigen and Aqueti are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Bioptigen and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes